00759nam0-22002771i-450-99000031208040332120001010000031208FED01000031208(Aleph)000031208FED0100003120820001010d--------km-y0itay50------baitay-------001yy<<Les >>huiles & graisses d'origine animale.Par J. FritschParisLibrairie generale scientifique & industrielle H. Desforges1907407 p. 23 ill., 24 cm660Fritsch,J.ITUNINARICAUNIMARCBK99000031208040332104 110-10CI 01131DINCHDINCHUNINAING0100942nam0-2200301---450-99000937376040332120110609105856.0000937376FED01000937376(Aleph)000937376FED0100093737620110608d2009----km-y0itay50------baengUSy-------001yyStalin's policepublic order and mass repression in the USSR, 1926-1941Paul HagenlohWashington, D.C.Woodrow Wilson Center PressBaltimoreThe Johns Hopkins University Press2009xix,460 p.23 cmPersecuzione politicaUnione SovieticaStoria947.084221itaHagenloh,Paul511342ITUNINAREICATUNIMARCBK990009373760403321XIV B 224747350FSPBCFSPBCStalin's police762095UNINA03948nam 2200865z- 450 991055729760332120210501(CKB)5400000000041063(oapen)https://directory.doabooks.org/handle/20.500.12854/69163(oapen)doab69163(EXLCZ)99540000000004106320202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBotulinum Toxin Treatment for Pain and Inflammation in Functional Urological DisordersBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (196 p.)3-03936-670-X 3-03936-671-8 The botulinum toxin has been widely applied in the treatment of functional urological diseases, such as overactive bladder, neurogenic detrusor overactivity, interstitial cystitis, and chronic pelvic pain syndrome. Evidence has shown that the botulinum toxin not only affects the release of neuropeptides from motor nerve endings, but also connects sensory nerves to the central nervous system. Inflammation in the central nervous system can be reduced after botulinum toxin treatment. The scope of therapeutic targets involves detrusor overactivity, sensory disorders, bladder pain and pelvic pain, and inflammatory disorders of the bladder, prostate, and bladder outlet. Although the actual pathophysiological mechanism of the action of the botulinum toxin has not been completely demonstrated, an anti-inflammation effect might be the predominant therapeutic mechanism for functional urological disorders such as an overactive bladder, bladder hypersensitivity, interstitial cystitis, chronic pelvic pain syndrome, chronic prostatitis, and lower urinary tract symptoms/benign prostatic hyperplasia. This Special Issue of Toxins covers the therapeutic potentials of the botulinum toxin on lower urinary tract dysfunctions, with emphasis on the mechanism of pharmacological action and clinical effects.Medicine and Nursingbicsscantimuscarinicsbenign prostatic hyperplasiabladderbladder painbotulinum toxinBotulinum toxinbotulinum toxin Achronic pelvic pain syndromechronic prostatitisdiabetes mellitusdrug deliveryfunctional urological disordersfunctional urology disorderhumanhydrodistentioninflammationinterstitial cystitislower urinary tract symptomsmaximal bladder capacitymid-urethral slingmolecular mechanismnetwork meta-analysisneurogenic detrusor overactivityonabotulinumtoxinAOnabotulinumtoxinAoveractive bladderpainpainful bladder syndromepathophysiologypelvic painperipheral tibial nerve stimulationpredictorprostatitissacral neuromodulationsensationtherapeutic outcometherapytreatmenturethraurethral sphincterurethral sphincter dysfunctionurinary incontinenceurodynamicsvoidingMedicine and NursingKuo Hann-Chorngedt1281276Kuo Hann-ChorngothBOOK9910557297603321Botulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders3018456UNINA